Relationship of A1c and mortality in heart failure patients with diabetes.
Read More »EASD: New Drug Taken with Insulin Improves Efficacy
A new product that is taken along with insulin improves absorption and increased peak insulin concentrations, therefore allowing better glucose control.
Read More »EASD: Insulin Pump and Sensor More Effective than Multiple Daily Injections
A sensor-augmented pump (SAP), which combines an insulin pump with a continuous glucose sensor, delivers lower hemoglobin (Hb)A1c levels than multiple daily injections, without an increase in hypoglycemia. This finding potentially moves pumps a step nearer to the ultimate aim of a closed system and greater control and convenience for patients …
Read More »EASD: Hypoglycemia Associated with Increased Risk of MI
A new case-control study has shown that an episode of hypoglycemia in diabetes patients is associated with a higher risk of MI for the following two weeks and possibly for a few months afterward.
Read More »EASD: Metformin Improves Endothelial Function in Type 2 Diabetes
Researchers reported at EASD that metformin appears to have specific effects on endothelial function, which might help explain why metformin treatment is associated with decreased risk of cardiovascular disease in Type 2 diabetes.
Read More »Antioxidants Can Raise Diabetes Risk
Instead of protecting against diabetes, antioxidants — compounds in foods and supplements that prevent cell damage — may actually increase the chances of getting diabetes, at least in the early stages, researchers reported.
Read More »Body’s Circadian Rhythm Tightly Entwined with Blood Sugar Control
Scientists have long struggled to understand the body’s biological clock. Its tick-tock wakes us up, reminds us to eat and tells us when to go to bed. But what sets that circadian rhythm?
Read More »EASD: Lidocaine Patch Beats Pregabalin for Diabetic Nerve Pain
A dermal patch containing 5% lidocaine (Lidoderm) proved as effective as pregabalin (Lyrica) in relieving neuropathic pain in diabetic patients with dramatically fewer side effects.
Read More »EASD: New First in Class Drug Effective in Phase III Trial
An investigational drug targeting an insulin-independent pathway in Type 2 diabetes produced early and substantial reductions in blood glucose and body weight in a phase III study.
Read More »EASD: Link Between Severe Mental Illness, CVD, Diabetes
European organizations are calling for improved care and screening for CVD and diabetes in those with mental illnesses.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.